Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2/3 agonists

Behavioural Pharmacology

Volumn 15, Issue 1, 2004, Pages 75-83

  Cook, C D ^a   Beardsley, P M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

7 OH DPAT; Drug discrimination; Heroin training dose; Methadone; Morphine; Nalbuphine; Quinelorane; Quinpirole; Rat

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXY 1,2,3,4 TETRAHYDRONAPHTHALENE HYDROBROMIDE; DIAMORPHINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; METHADONE; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALBUPHINE; QUINELORANE; QUINPIROLE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; MALE; NONHUMAN; RAT; STIMULATION; TRAINING;

ANIMALS; APPETITIVE BEHAVIOR; BRAIN; DISCRIMINATION LEARNING; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HEROIN; MALE; METHADONE; MORPHINE; MOTIVATION; NALBUPHINE; QUINOLINES; QUINPIROLE; RATS; RATS, LONG-EVANS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, OPIOID, MU; TETRAHYDRONAPHTHALENES;

EID: 1242317108     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200402000-00009     Document Type: Article

References (42)

1. Aretha CW, Sinha A, Galloway MP (1995). Dopamine D3-preferring ligands act at synthesis modulating autoreceptors. J Pharmacol Exp Ther 274:609-613.
2. Christian AJ, Goodwin AK, Baker LE (2001). Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A. Pharmacol Biochem Behav 68:371-377.
3. Colpaert FC, Niemegeers JE, Janssen PA (1977). Differential haloperidol effect on two indices of fentanyl-saline discrimination. Psychopharmacology (Berl) 53:169-173.
4. 2/3 agonists and antagonists on the locomotor activating effects of morphine and caffeine in mice. Pharmacol Biochem Behav 75:363-371.
5. 2/3 antagonists. Behav Pharmacol 15:65-74.
6. Cook CD, Picker MJ (1998). Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons: importance of training dose and attenuation by the D3 agonist (±)-7-OH-DPAT. Psychopharmacology (Berl) 136:59-69.
7. 3 agonist 7-OH-DPAT. Psychopharmacology (Berl) 144:239-247.
8. Cook CD, Barrett AC, Roach EL, Bowman JR, Picker MJ (2000a). Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor. Psychopharmacology (Berl) 150:430-442.
9. 3/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats. Psychopharmacology (Berl) 152:93-104.
10. Cook CD, Barrett AC, Syvanthong C, Picker MJ (2000c). Modulatory effects of dopamine D3/2 agonists on kappa opioid-induced antinociception and diuresis in the rat. Psychopharmacology (Berl) 152:14-23.
11. 3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens. Psychopharmacology (Berl) 160:307-317.
12. Dekeyne A, Rivet JM, Gobert A, Millan MJ (2001). Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128, 907 and 7-OH-DPAT. Neuropharmacology 40:899-910.
13. Dettmar PW, Cowan A, Walter DS (1981). A comparison of the neurochemical effects of buprenorphine with those of morphine and haloperidol in rats. Eur J Pharmacol 69:147-153.
14. Di Chiara G, Imperato A (1988). Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080.
15. Drukarch B, Stoof JC (1990). D-2 dopamine autoreceptor selective drugs: do they really exist? Life Sci 47:361-376.
16. Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS (1996). In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis. Eur J Pharmacol 308:261-269.
17. Gauvin DV, Young AM (1989). Evidence for perceptual masking of the discriminative morphine stimulus. Psychopharmacology (Berl) 98:212-221.
18. Gilbert DB, Millar J, Cooper SJ (1995). The putative dopamine D3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum. Brain Res 681:1-7.
19. Gilliland SL, Alper RH, Levant B (2000). Pharmacology of quinpirole-stimulated [35S]GTPgammaS binding: discrepancy with receptor binding profile. Eur J Pharmacol 392:125-128.
20. 3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J Pharmacol Exp Ther 275:899-913.
21. Institute of Laboratory Animal Resources (1996). Guide for the Care and Use of Laboratory Animals. Washington DC: National Academy Press.
22. lyengar S, Kim HS, Wood PL (1987). Agonist action of the agonist/antagonist analgesic butorphanol on dopamine metabolism in the nucleus accumbens of the rat. Neurosci Lett 77:226-230.
23. Kamei J, Saitoh A (1996). Modification of the effects of 7-OH-DPAT, a dopamine D3-receptor agonist, on morphine-induced hyperlocomotion by diabetes. Life Sci 59:773-780.
24. Koeltzow TE, Xu M, Cooper DC, Hu X-T, Tonegawa S, Wolf ME, White FJ (1998). Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J Neurosci 18:2231-2238.
25. Levant B (1997). The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49:231-252.
26. Levant B, Bancroft GN, Selkirk CM (1996a). In vivo occupancy of D2 dopamine receptors by 7-OH-DPAT. Synapse 24:60-64.
27. Levant B, Moehlenkamp JD, Morgan KA, Leonard NL, Cheng CC (1996b). Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site. J Pharmacol Exp Ther 278:145-153.
28. Morgan MJ, Franklin KBJ (1991). Dopamine receptor subtypes and formalin test analgesia. Pharmacol Biochem Behav 40:317-322.
29. Newman JL, Vann RE, May EL, Beardsley PM (2002). Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats. Psychopharmacology (Berl) 164:108-114.
30. Picker MJ, Dykstra LA (1989). Discriminative stimulus effects of mu and kappa opioids in the pigeon: Analysis of the effects of full and partial mu and kappa agonists. J Pharmacol Exp Ther 249:557-566.
31. Rodriguez de Fonseca F, Rubio P, Martin-Calderon JL, Caine SB, Koob GF, Navarro M (1995). The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. Eur J Pharmacol 274:47-55.
32. Sanger DJ, Depoortere R, Perrault G (1997). Discriminative stimulus effects of apomorphine and 7-OH-DPAT: a potential role for dopamine D3 receptors. Psychopharmacology (Berl) 130:387-395.
33. Sotnikova TD, Gainetdinov RR, Grekhova TV, Rayevsky KS (2001). Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study). Pharmacol Res 43:283-290.
34. Suzuki T, Maeda J, Funada M, Misawa M (1995). The D3-receptor agonist (±)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice. Neurosci Lett 187:45-48.
35. Varty GB, Higgins GA (1997). Investigations into the nature of a 7-OH-DPAT discriminative cue: comparison with D-amphetamine. Eur J Pharmacol 339:101-107.
36. Walker EA, Picker MJ, Dykstra LA (2001). Three-choice discrimination in pigeons is based on relative efficacy differences among opioids. Psychopharmacology (Berl) 155:389-396.
37. Wise RA, Leone P, Rivest R, Leeb K (1995). Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. Synapse 21:140-148.
38. Wood PL (1983). Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences. Peptides 4:595-601.
39. Wood PL, McQuade P, Richard JW, Thakur M (1983). Agonist/antagonist analgesics and nigrostriatal dopamine metabolism in the rat: evidence of receptor dualism. Life Sci 33:759-762.
40. Young AM, Masaki MA, Geula C (1992). Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. J Pharmacol Exp Ther 261:246-257.
41. Zhang L, Walker EA, Sutherland J, Young AM (2000). Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids. Psychopharmacology (Berl) 148:136-145.
42. Zuch CL, Cory-Slechta DA (2001). Stimulus properties of 7-OH-DPAT versus auto- and postsynaptic receptor-specific doses of quinpirole. Pharmacol Biochem Behav 68:469-479.